# A Prospective Clinical Study to Evaluate the Safety and Effectiveness of Pulmonary Vein Isolation Plus Box Isolation of Fibrotic Areas With the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

> **NCT06973031** · NA · RECRUITING · sponsor: **Kardium Inc.** · enrollment: 115 (estimated)

## Conditions studied

- Paroxysmal Atrial Fibrillation (PAF)
- Persistent Atrial Fibrillation

## Interventions

- **DEVICE:** Globe Pulsed Field System

## Key facts

- **NCT ID:** NCT06973031
- **Lead sponsor:** Kardium Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-10
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 115 (ESTIMATED)
- **Last updated:** 2025-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06973031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06973031, "A Prospective Clinical Study to Evaluate the Safety and Effectiveness of Pulmonary Vein Isolation Plus Box Isolation of Fibrotic Areas With the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06973031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*